Raimundas Venckus1, Marius Jasenas1, Titas Telksnys1, Martynas Venckus2, Vinsas Janusonis3, Audrius Dulskas4,5, Narimantas E Samalavicius1,2,6. 1. Department of Surgery, Klaipeda University Hospital, 41 Liepojos Str., 92288, Klaipeda, Lithuania. 2. Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. 3. Klaipeda University Hospital, 41 Liepojos Str., 92288, Klaipeda, Lithuania. 4. Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. audrius.dulskas@gmail.com. 5. Department of Abdominal and General Surgery and Oncology, National Cancer Institute, 1 Santariskiu Str., LT-08406, Vilnius, Lithuania. audrius.dulskas@gmail.com. 6. Health Research and Innovation Science Center, Faculty of Health Sciences, Klaipeda University, 84 Herkaus Manto Str., Klaipeda, Lithuania.
Abstract
OBJECTIVE: To describe our institution's initial experience with robot-assisted radical prostatectomy (RARP) using the Senhance® robotic system. PATIENTS AND METHODS: A prospective analysis of 127 robot-assisted radical prostatectomies was performed. Patient demographics, preoperative and intraoperative parameters, histopathological examination results, intraoperative and early postoperative complications were obtained and analyzed. RESULTS: The median patient age was 61.0 ± 6.36 (from 37 to 73) years, with a mean body mass index of 26.2 ± 3.79 kg/m2. Of 127 patients, 16.5% (n = 21) underwent a pelvic lymph node dissection, 29.1% (n = 37) underwent one sided or bilateral nerve sparing. Post-operative extracapsular invasion (≥ pT3) was found in 15% (n = 19) of the cases and a Gleason score ≥ 7 in 74.8% of all patients. Our median operative time was 180 ± 41.98 min [interquartile range (IQR) 150-215], and median blood loss was 250 ± 236 (IQR 175-430) ml. Of 127 patients, 33.9% (n = 43) had positive margins, of them 28.7% in pT2 and 57.9% in pT3. Fifteen patients (11.8%) experienced complications, of them only three had Clavien-Dindo ≥ 3. Operation time decreased by about 60 min and estimated blood loss decreased by about 200 ml from the initial experience of each surgeon. CONCLUSIONS: Robotic prostatectomy using a Senhance® robotic system is feasible, and warrants further study to determine whether it can improve patient outcomes.
OBJECTIVE: To describe our institution's initial experience with robot-assisted radical prostatectomy (RARP) using the Senhance® robotic system. PATIENTS AND METHODS: A prospective analysis of 127 robot-assisted radical prostatectomies was performed. Patient demographics, preoperative and intraoperative parameters, histopathological examination results, intraoperative and early postoperative complications were obtained and analyzed. RESULTS: The median patient age was 61.0 ± 6.36 (from 37 to 73) years, with a mean body mass index of 26.2 ± 3.79 kg/m2. Of 127 patients, 16.5% (n = 21) underwent a pelvic lymph node dissection, 29.1% (n = 37) underwent one sided or bilateral nerve sparing. Post-operative extracapsular invasion (≥ pT3) was found in 15% (n = 19) of the cases and a Gleason score ≥ 7 in 74.8% of all patients. Our median operative time was 180 ± 41.98 min [interquartile range (IQR) 150-215], and median blood loss was 250 ± 236 (IQR 175-430) ml. Of 127 patients, 33.9% (n = 43) had positive margins, of them 28.7% in pT2 and 57.9% in pT3. Fifteen patients (11.8%) experienced complications, of them only three had Clavien-Dindo ≥ 3. Operation time decreased by about 60 min and estimated blood loss decreased by about 200 ml from the initial experience of each surgeon. CONCLUSIONS: Robotic prostatectomy using a Senhance® robotic system is feasible, and warrants further study to determine whether it can improve patient outcomes.
Authors: Tomislav Kulis; Tvrtko Hudolin; Luka Penezic; Toni Zekulic; Hrvoje Saic; Nikola Knezevic; Zeljko Kastelan Journal: Int J Med Robot Date: 2021-11-03 Impact factor: 2.547